Publications

Bannière-U676-Y

[Coordonnées & contacts] [Publications]

Modulation de l'excitabilité neuronale par les neuropeptides

Publications originales

2005

  1. Zsolt Csaba, Susanne Pirker, Benjamin Lelouvier, Axelle Simon, Catherine Videau, Jacques Epelbaum, Thomas Czech, Christoph Baumgartner, Günther Sperk and Pascal Dournaud. Somatostatin receptor type 2 undergoes plastic changes in the human epileptic dentate gyrus. Journal of Neuropathology and Experimental Neurology, 2005; In press.
     
  2. Assemat E, Chatelet F, Chandellier J, Commo F, Cases O, Verroust P, Kozyraki R. Overlapping expression patterns of the multiligand endocytic receptors cubilin and megalin in the CNS, sensory organs and developing epithelia of the rodent embryo. Gene Expr Patterns, 2005; In press
     
  3. Claperon A, Hattab C, Armand V, Trottier S, Bertrand O and Ouimet T. Regional and cellular localisation of the Kell and Kx proteins in the central nervous system. Neuroscience, 2005; In press.
     
  4. Gingras H, Cases O, Krasilnikova M, Berube G, Nepveu A. Biochemical characterization of the mammalian Cux2 protein. Gene, 2005; 344:273-285.
     
  5. Voisin S. and Ouimet T The ultimate tryptophan residue of Neprilysin 2 is not involved in protein maturation and enzymatic activity. Biochem. Biophys. Res. Com, 2005; 335: 356-360.
     
  6. Claperon A, Rose C, Collec E, Bertrand O and Ouimet T The Kell protein of the common K2 phenotype is a catalytically active metalloprotease whereas the rare Kell K1 antigen is inactive. J. Biol. Chem, 2005; 280 (22): 21272-21283.
     
  7. Marie-Hélène Bassant, Axelle Simon, Frédérique Poindessous-Jazat, Zsolt Csaba, Jacques Epelbaum and Pascal Dournaud. Medial septal GABAergic neurons express the somatostatin sst2A receptor: functional consequences on unit firing and hippocampal theta. Journal of Neuroscience, 2005; 25(9) 1-10.

 

2004

  1. Voisin S, Rognan D, Gros C and Ouimet T A three-dimensional model of the neprilysin 2 active site based on the X-ray structure of neprilysin: identification of residues involved in substrate hydrolysis and inhibitor binding. J. Biol. Chem., 2004; 279 (44): 46172-81.
     
  2. Funalot B, Ouimet T, Claperon A, Fallet C, Delacourte A, Epelbaum J, Subkowski T, Léonard N, Codron V, David JP, Amouyel P, Schwartz JC, Helbecque N Endothelin-converting enzyme-1 is expressed in human cerebral cortex protects against Alzheimer’s disease. Mol. Psychiatry, 2004; 9(12):1122-8.
     
  3. Csaba Z, Richichi C, Bernard V, Epelbaum J, Vezzani A and Dournaud P. Plasticity of somatostatin and somatostatin sst2A receptors in the rat dentate gyrus during kindling epileptogenesis. European Journal of Neuroscience, 2004 ; 19 :2531-8.

 

2003

  1. Vitalis T, Alvarez C, Chen K, Shih JC, Gaspar P, Cases O. Developmental expression pattern of monoamine oxidases in sensory organs and neural crest derivatives. J Comp Neurol, 2003; 464(3):392-403.
     
  2. Facchinetti P, Rose C, Schwartz JC and Ouimet T. Ontogeny, regional and cellular distribution of the novel metalloprotease Neprilysin 2 in the rat: A comparison with Neprilysin and Endothelin-Converting-Enzyme-1. Neuroscience, 2003; 118(3):627-39.
     
  3. Winsky-Sommerer R, Grouselle D, Rougeot C, Laurent V, David JP, Delacourte A, Dournaud P, Seidah NG, Lindberg I, Trottier S, Epelbaum J. The proprotein convertase PC2 is involved in the maturation of prosomatostatin to somatostatin-14 but not in the somatostatin deficit in Alzheimer’s disease. Neuroscience, 2003;122(2):437-47.
     
  4. Z. Csaba, A simon, L Helboe, J Epelbaum and P Dournaud. Targeting sst2A-receptor expressing cells in the rat hypothalamus through in vivo agonist stimulation: neuroanatomical evidence for a major role of this subtype in mediating somatostatin functions. Endocrinology, 2003, 144(4):1564-73.
     
  5. Stéphane Peineau, Brigitte Potier, Florence Petit, Pascal Dournaud, Jacques Epelbaum, and Robert Gardette. AMPA-sst2 somatostatin receptor interaction in rat hypothalamus requires activation of NMDA and/or metabotropic glutamate receptors and depends on intracellular calcium. Journal of Physiology (London) 2003 1;546:101-17.
     
  6. Fombonne J, Csaba Z, Von Boxberg Y, Valayer A, Rey C, Benahmed M, Dournaud P and Krantic S. Expression of somatostatin receptor type-2 (sst2A) in immature porcine Leydig cells and a possible role in the local control of testosterone secretion. Reprod Biol Endocrinol. 2003 ;1(1):19.

 

2002

  1. Vitalis T, Fouquet C, Alvarez C, Seif I, Price D, Gaspar P, Cases O. b. Developmental expression of monoamine oxidases A and B in the central and peripheral nervous systems of the mouse. J Comp Neurol, 2002; 442(4):331-347.
     
  2. Vitalis T, Cases O, Gillies K, Hanoun N, Hamon M, Seif I, Gaspar P, Kind P, Price DJ. Interactions between TrkB signaling and serotonin excess in the developing murine somatosensory cortex: a role in tangential and radial organization of thalamocortical axons. J Neurosci, 2002; 22(12):4987-5000.
     
  3. Marillat V, Cases O, Nguyen-Ba-Charvet KT, Tessier-Lavigne M, Sotelo C, Chedotal A.. Spatiotemporal expression patterns of slit and robo genes in the rat brain. J Comp Neurol, 2002; 442(2):130-155.
     
  4. Laurent A, Goaillard JM, Cases O, Lebrand C, Gaspar P, Ropert N. Activity-dependent presynaptic effect of serotonin 1B receptors on the somatosensory thalamocortical transmission in neonatal mice. J Neurosci, 2002; 22(3):886-900.
     
  5. Alvarez C, Vitalis T, Fon EA, Hanoun N, Hamon M, Seif I, Edwards R, Gaspar P, Cases O. Effects of genetic depletion of monoamines on somatosensory cortical development. Neuroscience, 2002 ; 115(3):753-764.
     
  6. Rose C, Voisin S, Gros C, Schwartz J.C. and Ouimet T. Cell specific activity of  Neprylsin 2 isoforms and enzymatic specificity compared to Neprilysin. Biochem. J., 2002, 363(3): 697-705.
     
  7. Chotard C, Ouimet T, Morisset S, Sahm U, Schwartz JC and Trottier S Effects of histamine H3 receptor agonist and antagonist on histamine co-transmitter expression in rat brain.  J. Neural Transmission, 2002; 109: 293-306.
     
  8. Csaba Z, Simon A, Helboe L, Epelbaum J and Dournaud P. Neurochemical characterization of receptor-expressing cell populations by in vivo agonist-induced internalization: insights from the somatostatin sst2A receptor. Journal of Comparative Neurolology, 2002, 454- (192-199)
     
  9. Moneta D, Richichi C, Aliprandi M, Dournaud P, Dutar P, Billard JM, Carlo AS, Viollet C, Hannon JP, Fehlmann D, Nunn C, Hoyer D, Epelbaum J and Vezzani A. Somatostatin receptor subtypes 2 and 4 affect seizure susceptibility and hippocampal excitatory neurotransmission in mice. European Journal of Neuroscience, 2002, Vol 16, 1-19.

 

2001

  1. Auso E, Cases O, Fouquet C, Camacho M, Garcia-Velasco JV, Gaspar P, Berbel P. Protracted expression of serotonin transporter and altered thalamocortical projections in the barrelfield of hypothyroid rats. Eur J Neurosci, 2001. 14(12):1968-1980.
     
  2. Csaba Z, Bernard V, Helboe L, Bluet-Pajot MT, Bloch B, Epelbaum J and Dournaud P. In vivo internalization of the somatostatin sst2A receptor in rat brain : evidence for translocation of cell-surface receptors into the endosomal recycling pathway. Molecular and Cellular Neuroscience, 2001 ; 17 :646-661.

 

2000

  1. Vitalis T, Cases O, Engelkamp D, Verney C, Price DJ. Defect of tyrosine hydroxylase-immunoreactive neurons in the brains of mice lacking the transcription factor Pax6. J Neurosci, 2000; 20(17):6501-6516.
     
  2. Ouimet T, Facchinetti P, Rose C, Bonhomme MC, Gros C, Schwartz JC. Neprilysin II: a novel metalloprotease and its isoforms in CNS and testis.  Biochem. Biophys. Res. Com, 2000; 271 (3) 565-570
     
  3. Lanneau C, Bluet-Pajot M.T., Zizzari P., Csaba Z., Dournaud P., Helboe L., Hoyer D., Pelligrini E., Tannenbaum G., Epelbaum E. and Gardette R. Involvement of the sst1 somatostatin receptor subtype in the intrahypothalamic neuronal network regulating Growth Hormone secretion: an in vitro and in vivo antisense study. Endocrinology, 2000 ; 141: 967-979.
     
  4. Winsky-Sommerer R., Benjannet S., Rovère C, Barbero P, Seidah N. G, Epelbaum J. and Dournaud P. Regional and cellular localization of the neuroendocrine prohormones convertases PC1 and PC2 in the rat central nervous system. Journal of Comparative Neurology,  2000 ; 424:439-460.

 

1999

  1. Vasilaki A, Lanneau C, Dournaud P, De Lecea L, Gardette R and Epelbaum J: Cortistatin affects glutamate sensitivity in mouse hypothalamic neurons through activation of sst2 somatostatin receptor subtype. Neuroscience, 1999; 88: 359-364.

 

1998

  1. Vitalis T, Cases O, Callebert J, Launay JM, Price DJ, Seif I, Gaspar P. Effects of monoamine oxidase A inhibition on barrel formation in the mouse somatosensory cortex: determination of a sensitive developmental period. J Comp Neurol, 1998; 393(2):169-184.
     
  2. Lebrand C, Cases O, Wehrle R, Blakely RD, Edwards RH, Gaspar P. Transient developmental expression of monoamine transporters in the rodent forebrain. J Comp Neurol, 1998; 401(4):506-524.
     
  3. Cases O, Lebrand C, Giros B, Vitalis T, De Maeyer E, Caron MG, Price DJ, Gaspar P, Seif I. Plasma membrane transporters of serotonin, dopamine, and norepinephrine mediate serotonin accumulation in atypical locations in the developing brain of monoamine oxidase A knock-outs. J Neurosci 1998; 18(17):6914-6927.
     
  4. Dournaud P, Boudin H,  Schonbrunn A, Tannenbaum GS and Beaudet A: Interrelationships between somatostatin SST2A receptors and somatostatin-containing axons in rat brain: evidence for regulation of cell surface receptors by endogenous somatostatin. Journal of Neuroscience, 1998 ; 18: 1056-40171.
     
  5. Grouselle D., Winsky-Sommerer R., David J.P., Delacourte A., Dournaud P. and Epelbaum J. Loss of somatostatin-like immunoreactivity in the frontal cortex of Alzheimer patients carrying the apolipoprotein epsilon 4 allele. Neuroscience Letters, 1998; 255:21-24.

 

1997

  1. Ouimet T, Castellucci VF. Gene expression and regulation of Aplysia californica pro-hormone convertases aPC1 and aPC2. J. Neurochem., 1997; 68 (3): 1031-1040.

 

1996

  1. Lebrand C, Cases O, Adelbrecht C, Doye A, Alvarez C, El Mestikawy S, Seif I, Gaspar P. Transient uptake and storage of serotonin in developing thalamic neurons. Neuron, 1996; 17(5):823-835.
     
  2. Cases O, Vitalis T, Seif I, De Maeyer E, Sotelo C, Gaspar P. 1. Lack of barrels in the somatosensory cortex of monoamine oxidase A-deficient mice: role of a serotonin excess during the critical period. Neuron, 1996 ; 16(2):297-307.
     
  3. Dournaud P, Jazat-Poindessous, Slama A, Lamour Y and Epelbaum J: Correlations between water maze performance and cortical somatostatin mRNA and high-affinity binding sites during ageing in rats. European Journal of Neuroscience, 1996 ; 8: 476-485.
     
  4. Dournaud P, Gu YZ, Schonbrunn A, Mazella J, Tannenbaum GS and Beaudet A: Localization of the somatostatin receptor sst2A in rat brain using a specific anti-peptide antibody. Journal of Neuroscience, 1996; 16: 4468-4478.

 

1995

  1. Cases O, Seif I, Grimsby J, Gaspar P, Chen K, Pournin S, Muller U, Aguet M, Babinet C, Shih JC, et al. Aggressive behavior and altered amounts of brain serotonin and norepinephrine in mice lacking MAOA. Science, 1995. 268(5218):1763-1766.
     
  2. Dournaud P., Delaere P., Hauw J.J. and Epelbaum J. Differential correlation between neurochemical deficits, neuropathology and cognitive status in Alzheimer’s disease. Neurobiology of Aging, 1995; 16: 817-823.

 

1994

  1. Ichai C., Chevallier N., Delaere P., Dournaud P., Epelbaum J., Hauw J.J., Vincent J.P. and Checler F. Influence of region-specific alterations of neuropeptidase content on the catabolic fates of neuropeptides in Alzheimer’s disease. Journal of Neurochemistry, 1994; 62: 645-655.
     
  2. Dournaud P., Cervera-Pierot P., Hirsch E., Javoy-Agid F., Kordon C., Agid Y. and Epelbaum J. Somatostatin messenger RNA-containing neurons in Alzheimer’s disease : an in situ hybridization study in hippocampus, parahippocampal cortex and frontal cortex. Neuroscience, 1994; 6: 755-764.
     
  3. Dournaud P., Gautron J.P., Pattou E., Bons B., Mestre N., Petter A., Kordon C. and Epelbaum J. Choline acetyltransferase and somatostatin levels in aged microcebus murinus brain. Neurobiology of Aging, 1994; 15: 727-731.

 

1993

  1. Ouimet T, Mammarbachi A, Cloutier T, Seidah NG, Castellucci VFCDNA structure and in situ localization of the Aplysia cali-fornica pro-hormone convertase PC2. Federation of European Biochemical Societies FEBS, 1993; 330: 343-346.
     
  2. Bertholet J.Y., Dournaud P. and Sarriau A. No aging effect on hippocampal type II glucocorticoid receptors in two inbred mouse strains. Neurobiology of Aging, 1993; 14: 97-99.

 

1992

  1. Bertherat J., Dournaud P., Berod A., Normand E., Bloch B., Rostene W., Kordon C and Epelbaum J. Growth hormone-releasing hormone-synthesizing neurons are a subpopulation of somatostatin receptor-labelled cells in the rat arcuate nucleus: a combined in situ hybridization and receptor light-microscopic radioautographic study. Neuroendocrinology, 1992 ; 56: 25-31.
     
  2. Giaid A, Masaki T, Ouimet T, Yanagisawa M, Gaspar L, Cantin M, Kimura S, Castellucci VF. Expression of Endothelin-like Peptide in the Nervous System of the Marine Mollusk Aplysia. J. of Cardiovascular Pharmacology, 1991; 17(Suppl. 7):449-451.

 

 

Revues générales et publications didactiques sur invitation

  1. Vitalis T, Cases O, Parnavelas JG.. Development of the dopaminergic neurons in the rodent brainstem. Exp Neurol, 2005; 191 Suppl 1:S104-112.
     
  2. Ouimet T. Neprilysin 2: A novel messenger peptide inactivating metalloprotease. Protein and peptide letters, special issue, 2004; 11(5):479-489.
     
  3. Gaspar P, Cases O, Maroteaux L.The developmental role of serotonin: news from mouse molecular genetics. Nat Rev Neurosci 2003; 4(12):1002-1012.
     
  4. Ouimet T. Le catabolisme des peptides Beta-amyloides dans le cerveau: une nouvelle fonction pour la Néprilysine. Médecine Sciences, 2001 ; 17: 1091.
     
  5. Csaba Z and Dournaud P. Molecular and cellular biology of somatostatin receptors. Neuropeptides. 2001 ; 35 : 1-23.
     
  6. Winsky-Sommerer R, Dournaud P, Epelbaum J. Neuropeptides, vieillissement cérébral et démences séniles. L’Année Gérontologique, 2001 ; 15 163-182
     
  7. Dournaud P, Slama A, Beaudet A, Epelbaum J: Somatostatin receptors in the central nervous system. In Handbook of Chemical Neuroanatomy, 2000, Vol 16: Peptide receptors, Part I: 1-43. Edited by R. Quirion, A Björklund and T. Hökfelt, Elsevier Science Publishers, Amsterdam.
     
  8. Beaudet A, Dournaud P., Boudin H. Complementarity of radioautographic and immunohistochemical techniques for localizing  neuroreceptors at the light and electron microscopy level. Braz. J. Med. Biol. Res. 1998 ; 31: 215-223.
     
  9. Epelbaum J., Dournaud P . Somatostatin: an ubiquitous peptide. C. R. Seances Soc. Biol. 1998; 192: 1-10.
     
  10. Tostivint H., Lihrmann I., Bucharles C., Vieau D., Coulouarn Y., Vaudry H., Fournier A., Conlon JM., Dournaud P., Gardette R., Viollet C., Epelbaum J. A second somatostatin gene expressed in the brain. MS-Medecine Sciences, 1996; 12: 1131-1133.
     
  11. Schonbrunn A., Gu Y.Z., Dournaud P., Beaudet A., Tannenbaum G.S., Brown P.J. Somatostatin receptor subtypes: specific expression and signaling properties. Metabolism, 1996; 45: 8-11.
     
  12. Dournaud P., Epelbaum J. Somatostatine. Neuropeptides et Neuromédiateurs, 1995 ; 2 ème édition, Sandoz et INSERM éds,  pp 271-280.
    Epelbaum J., Dournaud P., Fodor M., Viollet C. The neurobiology of somatostatin. Crit. Rev. Neurobiol., 1994; 8: 25-44.
     
  13. Dournaud P., Epelbaum J. Somatostatine. Neuropeptides et Neuromédiateurs, 1992 ; 1ère édition, Sandoz éds; pp 271-280.
[Accueil] [Equipes] [Cerveau périnatal] [Mitochondrie] [Excitabilite neuronale] [Avenir] [Annonces] [Annuaire] [Publications] [EADs - EAMs] [Localisation] [Contacts] [Espace privé] [Liens utiles] [Plan du site]